Search
Dendritic cells vaccine
go.drugbank.com/drugs/DB15803InvestigationalAs of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials. … The recombinant chimeric DC vaccine is a subunit-based vaccine candidate investigated for safety and effectiveness against SARS-CoV-2-induced pneumonia.
Bombesin
go.drugbank.com/drugs/DB11724InvestigationalBombesin is under investigation in clinical trial NCT01205321 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86 … -7548 in Patients With Prostate Cancer and Healthy Volunteers).
BGT-DTDS
go.drugbank.com/drugs/DB18664ExperimentalIt is under investigation for the treatment of dopamine transporter deficiency syndrome (DTDS). … BGT-DTDS is an investigational gene therapy comprising an adeno-associated viral vector type 2 (AAV2) encoding the human _SLC6A3_ gene.
Cyfluthrin
go.drugbank.com/drugs/DB13828ExperimentalCategories: Compounds used in a research, industrial, or household settingStevioside
go.drugbank.com/drugs/DB16882InvestigationalCategories: Compounds used in a research, industrial, or household settingCypermethrin
go.drugbank.com/drugs/DB13721InvestigationalCategories: Compounds used in a research, industrial, or household settingNitecapone
go.drugbank.com/drugs/DB20402ExperimentalNitecapone is a small molecule drug. Nitecapone has a monoisotopic molecular weight of 265.06 Da.
Categories: Compounds used in a research, industrial, or household settingSerpinPC
go.drugbank.com/drugs/DB17698InvestigationalSerpinPC is a mutated alpha-1-antitrypsin (α1AT) and serine protease inhibitor being investigated for the treatment of hemophilia.[A258993]
Etavopivat
go.drugbank.com/drugs/DB18176InvestigationalEtavopivat is a small molecule activator of erythrocyte pyruvate kinase (PKR) under investigation for the treatment of sickle cell disease.
CLBS12
go.drugbank.com/drugs/DB18192InvestigationalCLBS12 is a GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of Buerger’s disease.